Method of predicting the responsiveness of a cancer disease to treatment on the basis of DNA methylation

摘要

The present invention relates to a method of predicting/determining the responsiveness of a cancer disease to treatment with an inhibitor of CD95/CD95L signalling comprising the steps of i) determining the methylation level of a DNA sequence located upstream of and/or in a gene involved in CD95/CD95L signalling in a sample obtained from a patient; and ii) predicting/determining the responsiveness of the cancer disease according to said methylation level.